A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)

Clinical trial NCT05667506 · RECRUITING

Trial details

NCT number: NCT05667506
Sponsor: Juventas Cell Therapy Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia

Start date: 2023-02-07
Primary completion: 2025-05-30
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.